Deuruxolitinib Phosphate Patent Expiration
Deuruxolitinib Phosphate was first introduced by Sun Pharmaceutical Industries Inc
Deuruxolitinib Phosphate Patents
Given below is the list of patents protecting Deuruxolitinib Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Leqselvi | US11919907 | Deuterated JAK inhibitor and uses thereof | May 21, 2041 | Sun Pharm Inds Inc |
| Leqselvi | US10561659 | Treatment of hair loss disorders with deuterated JAK inhibitors | May 04, 2037 | Sun Pharm Inds Inc |
| Leqselvi | US12076323 | Treatment of hair loss disorders with deuterated JAK inhibitors | May 04, 2037 | Sun Pharm Inds Inc |
Deuruxolitinib Phosphate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List